There is a reproducibility crisis in science. There are many potential contributors to replication failure in research across the translational continuum. In this perspective piece, we focus on the narrow topic of inferential reproducibility. Although replication of methods and results is necessary to demonstrate reproducibility, it is not sufficient. Also fundamental is consistent interpretation in the Discussion section. Current deficiencies in the Discussion sections of manuscripts might limit the inferential reproducibility of scientific research. Lack of contextualisation using systematic reviews, overinterpretation and misinterpretation of results, and insufficient acknowledgement of limitations are common problems in Discussion sections; these deficiencies can harm the translational process. Proposed solutions include eliminating or not reading Discussions, writing accompanying editorials, and post-publication review and comments; however, none of these solutions works very well. A second Discussion written by an independent author with appropriate expertise in research methodology is a new testable solution that could help probe inferential reproducibility, and address some deficiencies in primary Discussion sections.
assessments of prior probability and different choices regarding what to focus on in the analysis and reporting of data. 3 Most critiques regarding the quality of research publications focus on the Methods and Results sections, whereas the Introduction and Discussion sections have received less systematic scrutiny. 4 Some of the ongoing deficiencies of Discussion sections in medical journals include lack of contextualisation of results using systematic review, selective citation of prior studies that agree with the results, overinterpretation or misinterpretation of findings, and incomplete acknowledgement, analysis, and assessment of study limitations. 4e6 Considering that many clinicians and policy makers might form an opinion of the importance of a study based on the contents and tone of the Discussion and the Abstract alone, it is important that these sections should be dispassionate, appropriately informative, and demonstrably reproducible. Misleading Discussions can artificially fuel premature conclusions along the translational continuum.
Current deficiencies of discussion sections
Discussion sections of research articles can be subject to many problems. Interpretation by the investigators of their own results may be biased and researchers often do not appropriately contextualise the findings of studies within a broader scope of scientific evidence. 4,6e8 It has been suggested that failure to refer to relevant published literature in the Discussion section is unacceptable research practice, and authors should clarify what strategy they used to identify all relevant publications, 4 including unpublished (often negative) findings. This practice is not currently required by most journals. A conclusion is often preconceived in scientific manuscripts, and the Discussion misinterprets the results to yield the desirable conclusions. 7, 8 Results and their implications for clinical practice are interpreted based on unbalanced assumptions fuelled by confirmation or allegiance bias, sponsor interests, or both. The latter may be particularly influential when research has practical financial implications. Furthermore, exaggerations or misrepresentations in manuscript Discussions can be perpetuated or even further distorted in academic press releases and the resulting science news stories. 9 The main factor that has been associated with selective reporting of positive effects of experimental treatments has been the presence of such selective emphasis in an article's conclusion. 10 Accounting for the totality of evidence
Clinical research guidelines, such as the CONSORT statement, suggest that the results of a study should be interpreted in the context of the totality of available information. 11 Contextualising the results of studies using systematic review of relevant literature can help to ensure that new research builds on lessons from earlier research, and can assess whether findings from previous studies are replicated or contradicted. In three studies conducted over a decade, Clarke and Chalmers 4 and Clarke and colleagues 5, 6 showed that manuscripts in major medical journals have not embraced this recommendation, and most Discussion sections do not include systematic review in interpreting findings. It is clear, however, that the practice of systematic review or meta-analysis is not uniform or required in all major medical journals. It is unlikely that the situation is better in other journals. Absent systematic review, there is a tendency to preferentially cite studies with positive findings or findings congruent with authors' perspectives. 12e14 Selective citation in Discussion sections has the potential to distort scientific knowledge. 13 Such distortion can lead to the inappropriate translation of findings, such as the premature or indiscriminate clinical implementation of a protocol from a clinical trial.
Overinterpretation and misinterpretation of results
There are several motivations for overinterpreting and misinterpreting results, including confirmation bias, allegiance bias, and the desire to impact practice with positive results. For example, it is common to overinterpret the clinical applicability of diagnostic tests. 15 Indeed, the problem of overinterpretation and misreporting of results in Abstracts and Discussions in diagnostic accuracy studies has been found to be common even in journals with high journal impact factors. 16 An analysis of 76 trials of analgesic interventions revealed that treatment benefit is often portrayed despite non-'significant' primary findings, and even without 'significant' findings of effectiveness, investigators often recommend clinical adoption of analgesic treatments. 17 A concerning investigation of 72 RCTs with non-'significant' results revealed that 43% of the Discussion sections contained 'spin' or interpretations of findings that were inconsistent with the non-'significant' results. 18 Such 'spin' has also been reported in the titles and abstracts of papers in the leading anaesthesia journals. 19 Industry funding can produce allegiance bias, and numerous studies by Bero and colleagues 20 and Lundh and colleagues 21 have shown that industry funding is likely to influence the interpretation of clinical trials (more so than their results). The overinterpretation of 'significant' results also has the potential to create inaccurate scientific narratives that can persist in research or clinical practice. There is a false belief that the probability of a postulate being in error or that probable causality can be inferred from the data in a single experiment. 22 It is a common misconception that the P-value can be used for null hypothesis testing, and to suggest that it reflects the probability that the null hypothesis is true.
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Lack of appropriate discussion of limitations
One of the major problems with Discussion sections is that limitations of studies are not thoroughly addressed. 23 Although relatively common in clinical research, deficiency in addressing limitations is probably even more of a problem in basic (laboratory) research. 24 Insufficient acknowledgement of limitations in Discussion sections has previously been found to be among the most important deficiencies in scientific articles. 25 An examination of 400 articles published in 2005 in eight leading journals showed that only 17% used at least one word denoting limitations in the context of the presented work in the manuscript, and only five articles had a separate section on limitations. 23 These findings were reinforced in an analysis of 300 biomedical publications using linguistic software to detect expressions of uncertainty. 26 Researchers found that more than a quarter of studies did not acknowledge any limitations expressed in any way with some 'hedge' wording, and this was more likely in industry-funded studies. 26 A compelling argument has been made that articles that fully attempt to address limitations are likely to be widely cited and to shape the future research agenda. 27 However, it might remain difficult for investigators to address honestly the limitations of their research.
Potential solutions proposed to date
Several solutions have been proposed in the past to address the problem of misleading Discussions, but none seems to be fully satisfactory. One proposed solution is for readers to read only Methods and Results sections, and to interpret the manuscript by themselves without reference to the paper's Discussion. 28 It has also been argued that Discussion sections can be entirely eliminated. However, this solution seems suboptimal because an impartial and informative Discussion can and should provide readers with critical insights and context. Even an educated reader certainly cannot be expected to perform a systematic review of other available evidence. Furthermore, many consumers of scientific literature lack the analytical tools for evaluation and critical interpretation, and as such often read only the Abstract, Introduction, and Discussion. Scientific manuscripts can also be placed in context by editorials. However, an editorial typically focuses on limitations, contextualisation, and clinical implications; it can seldom explore the methods, results and interpretations of specific papers both comprehensively and in sufficient depth. Moreover, editorials legitimately can, by their very definition, be biased and are often intended to reflect one opinion. Post-publication review could also, in theory, achieve similar goals by providing critical review and alternative viewpoints as a paper evolves. Unfortunately, post-publication peer review has not been widely embraced in mainstream journals, and it might be perceived as powerless, as it often does not mandate response from the authors. 29 Initiatives such as PubMed Commons (now dismantled) and F1000 (https://f1000.com) have also aimed at enhancing post-publication peer review and discussion of the scientific literature.
An alternative approach: an independent second discussant
We propose that there should be two Discussion sections for scientific manuscripts, one of which would be written by the investigators, as is current practice, and the other would be authored independently of the research team. The investigators would make the protocol, Introduction, Methods, Results, and raw data (but not the Discussion section) available to an appropriate expert (or experts), who would be Table 1 Relevant extracts from the British Journal of Anaesthesia Instructions to Authors, detailing the desirable structure and contents of a Discussion section of a scientific manuscript State main findingsdThis does not mean a repetition of all the results with their statistics. It should provide a concise overview of the study. For example, 'Drug X produced a greater haemodynamic change on induction of anaesthesia than occurred with drug Y, resulting in a greater fall in arterial pressure and a higher incidence of tachycardia'. Do not repeat data already presented in the Results, figures, and tables. Relation to previous studiesdThis section should relate directly to the statements made in the Introduction and qualify your findings in relation to previous studies of the subject. Mention any important uncertainties in the methods of measurement. In laboratory studies, try to relate the concentrations used to those encountered clinically. Why are they different/samedAvoid excessive speculation or speculation beyond your results. It is quite reasonable to suggest possible explanations for your findings and any differences from previous studies, but the 'missing parts' of such reasoning must be acknowledged. Additions to knowledge of the subjectdSummarise previous sections by pulling together the implications of your main findings, studies by other workers and their combined contribution to our knowledge of the subject. This should not be just another repetition of the results and preceding discussion but more of an expanded conclusion. A meta-analysis incorporating the results of the new study and previous relevant studies could be included in this paragraph. Weaknesses and strengths in studydThis is the most important part of the Discussion. Acknowledge any limitations of your study at this point. Examples here could include the generalisability of the patient population, patients lost to follow-up (or missing data in general), and limitations of analytical test. Authors are advised to be honest but succinct in this section. It is also reasonable to comment briefly on the particular strengths of the study, especially in comparison with comparable studies. Future studiesdIdentify future studies that would address some of the potential explanations and limitations discussed earlier. This section should be very brief. ConclusionsdThe original contribution to knowledge from the present study should be stated. A common fault here is to overstate the findings from a study. It may be appropriate to give the implications of the conclusions for (anaesthetic) practice and the indications for further enquiry in this area of interest. Main Finding Original Discussion: 'In this large multicenter double-blind randomized clinical trial involving critically ill adults at high risk of delirium, there was no significant difference in the number of days survived at 28 days following inclusion between patients who received prophylactic haloperidol therapy and patients who received placebo. The pathophysiological mechanism of delirium is poorly understood. Delirium is considered a multifactorial disorder and many different pathways to its occurrence have been postulated resulting in many hypotheses. The fact that the average of 11 risk factors are present at the same time in ICU patients with delirium suggests the involvement of multiple pathways in its development. Therefore, it seems plausible that a mediator that alters causal pathways of delirium may be helpful. Haloperidol is an antipsychotic agent with antidopaminergic, antiadrenergic, limited anticholinergic properties and possibly has anti-inflammatory effects that potentially antagonizes multiple pathways of delirium.' 45 Independent Discussion: Delirium is associated with death. Haloperidol might prevent delirium in critically ill patients. Therefore, if haloperidol prevents delirium, it might also prevent death, assuming that delirium causes death. There was no evidence in this study that haloperidol compared with placebo increases or decreases 28 day mortality. Based on a precision estimate (95% confidence interval for the hazard ratio of 0.78e1.30), the results of this study remain consistent with a clinically meaningful decrease or increase in 28 day mortality attributable to haloperidol. Commentary: The original investigators provided rationale for the study in relation to delirium, but did not provide rationale in relation to the primary outcome, which was mortality. The summary of the main finding was the same (i.e. that there is no difference in mortality), although the independent discussant acknowledged also that clinically meaningful changes in mortality cannot be excluded. Relationship of Main Finding to Previous Studies Independent Discussion: Based on systematic review of the scientific literature, there is no previous evidence on the effectiveness of haloperidol prophylaxis in preventing mortality in critically ill patients. In other settings (e.g. those with myocardial infarction, dementia, or in nursing homes), there is some evidence that prophylactic haloperidol is associated with increased mortality. Overall, the evidence for a causal link between haloperidol and either increased or decreased mortality is weak. Commentary: In the original manuscript the Discussion did not contextualise the main finding in relation to previous studies, perhaps because this specific question has not previously been addressed. Additional (Secondary) Findings Original Discussion: 'Also, no significant differences were found in the number of days patients survived at 90 days between the haloperidol group and the placebo group. No differences were found for any other reported secondary end points. Furthermore, across predefined subgroups, the lack of a prophylactic effect was very consistent. Prophylactic haloperidol therapy was not associated with haloperidol-induced adverse effects.'
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Independent Discussion: There were no differences between groups in 90 day mortality, safety outcomes, delirium incidence, or any delirium related outcome. Higher APACHE-II (severity of acute illness) and PRE-DERELIC (delirium prediction) scores were independently associated with increased delirium risk and decreased survival. Delirium incidence was high (33%), as expected, in these critically ill patients. Surprisingly, the side-effects anticipated with haloperidol (sedation and prolonged QTc) were not seen in this study. Commentary: The summary of additional findings was similar in both Discussions. In both Discussions, surprise was expressed that there were no apparent side-effects or safety concerns with prophylactic (low dose) haloperidol. The independent Discussion addressed some predictive analyses that were not discussed in the original. Relationship of Additional (Secondary) Findings to Previous Studies Original Discussion: 'Haloperidol has been the first-line drug of choice to treat delirium for decades despite the lack of evidence that haloperidol is effective. For this reason, the Society of Critical Care Medicine in its last guideline on pain, agitation, and delirium did not recommend the use of haloperidol for treatment or for delirium prevention for critically ill adults. However, several ICU studies have evaluated possible prophylactic effects of haloperidol but demonstrate contradictory effects. In one randomized clinical trial, postoperative ICU patients received a maximum of 1.2 mg of haloperidol and showed a reduced delirium incidence and more delirium-free days. Another randomized clinical trial involving severely ill medical ICU patients receiving 2.5 mg 3 times daily, showed no beneficial effect, and no effect was found in reducing subsyndromal delirium with prophylactic haloperidol. Although a previous beforeeafter study showed clinical relevant and favorable effects in a similar group of high-risk and critically ill adults, these beneficial effects could not be replicated in the current randomized clinical trial. However, the findings of this study corroborate the findings of other randomized clinical trials involving critically ill adults.' 45 Independent Discussion: Studies have generally not found that haloperidol is effective in preventing or treating delirium. 50 Specifically, the evidence for haloperidol being effective at preventing delirium is sparse. Thus, the results of this trial are consistent with previous randomised trials. Commentary: There is agreement between the Discussions that the findings in relation to delirium prevention are largely consistent with the findings of previous randomised trials. Limitations: Original Discussion: 'This study has several limitations. First, the 1 mg haloperidol group was terminated early, as a predefined consequence of the adaptive design, which is considered a strength of our study. This discontinuation did not affect the presented study findings. Second, the duration of prophylactic therapy (median, 2 days) could be too short to prevent delirium and its deleterious outcome. It cannot be excluded that longer exposure to haloperidol may be needed to influence patient outcome. However, subgroup analysis in patients treated for more than 2 days also did not show any beneficial effect. Third, the dose may have been too low. In a beforeeafter study a 1 mg dose every 8 hours demonstrated beneficial effects without relevant adverse effects. For this reason, using a higher dose was included as part of the current study, similar to the study of Page et al. In both haloperidol dosage groups no beneficial effects were found. Fourth, it was not feasible to collect data for all secondary outcome measures in some centers due to research staff limitations. However, the median number of delirium-and coma-free days between both groups did not differ; therefore, collecting these data in a somewhat smaller group did not affect the results. Fifth, the study population included severely ill ICU adults, whose brains may have been too seriously affected for haloperidol to exert a prophylactic effect, since in non-ICU adults, prophylactic haloperidol may have beneficial effects. But the subgroup of patients Continued expected to write a second Discussion section for the manuscript. The primary author may propose potential independent second discussant(s), provided that transparent safeguards are in place about the impartiality of the selected scientist(s). Final choice would be up to the journal editors. As part of the second Discussion, the discussant could also specify whether and how he/she examined, probed, or scrutinised any of the data, analyses, and findings. With an increasing number of journals now requiring investigators to make available raw data and all versions of research protocols, 30e34 including for observational studies, 35 it is becoming feasible for a second discussant to judge the potential for selective reporting of outcomes, changes in analytic plans, and deviations from the protocol. The process will also make the original authors more likely to be transparent about such discrepancies with the original protocol and hopefully even prevent deviations from the original protocol.
The second discussant may communicate with the primary team to obtain clarifications on important but unclear matters. Primary investigators should also convey to the discussant any additional information that pertains to possible weaknesses of their study, especially those that may not be readily discernible to an outsider. Eventually, the second discussant should be able to make a balanced appraisal of the study, place it in the context of other literature and discuss its implications in a thorough and impartial way. We suggest that this novel approach to writing manuscripts could complement the tools and guidelines that are available for reporting of studies. 36 Importantly, such an approach would introduce another layer of checks and balances, which could help to prevent scientific misconduct through an impartial third party having direct access to the data and other study materials. As inferential reproducibility is the explicit goal of this approach, it is likely to influence the primary discussants to adopt a more objective and less sensationalist tone, and it would probably promote more stringent thresholds for claiming 'success.' 37 If the Discussion were demonstrably reproducible with this parallel approach, the credibility of the implications for medical practice would be enhanced, and suggestions regarding whether or not the findings of a study warranted a change in clinical care. 38 Conversely, a divergent second Discussion would represent a challenge to inferential reproducibility that might prompt a cautious re-evaluation of the original interpretation. Table 2 Continued with a low severity of illness score also demonstrated no beneficial effects. Nevertheless, it cannot be ruled out that delirium may be more easily and favorably affected in non-ICU adults than critically ill ICU adults. Sixth, the results of the long-term quality of life are not included herein, and therefore the effects of haloperidol on quality of life remain to be determined.'
Independent Discussion: A single study seldom provides definitive evidence, 51, 52 and although this was a 'negative' study (there were no estimated differences between the groups in the primary or secondary outcomes), the 95% confidence intervals for differences in both 28 day mortality (e3.4%e4.6%) and delirium (e4.6%e5.4%) included clinically important both benefit and harm. Because haloperidol was administered open label for treatment of delirium in both groups, its potential effectiveness for treatment could not be determined in this study. Delirium was not assessed in all the participating sites resulting in missing assessments; thus, the effective sample size for the delirium outcomes was reduced. It is possible that the dose of haloperidol was insufficient or that the time required for effective prophylaxis was insufficient. The hypothesis underpinning this study appears somewhat implausible.
In order for haloperidol to prevent death, it would have to be effective first in preventing delirium, and second delirium would have to be causally implicated in (rather than merely being associated with) mortality. Delirium is a complex syndrome that is likely to have multiple pathophysiological pathways 53 ; it is therefore improbable that any single intervention will have a marked impact on delirium incidence. Thus, the preestudy likelihood of a positive primary outcome with the intervention was low.
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Commentary: The main difference in emphasis was that the independent discussant noted the imprecision around the estimates for death and delirium. The independent discussant therefore inferred that this study should not be regarded as providing definitive evidence in relation to these questions. The independent discussant also felt that the initial premise behind this study was not compelling; there was no strong biological plausibility for the hypothesis. Both the independent Discussion and the original listed several limitations, with some overlap, but also differences, and these limitations can form a complementary list. Strengths: Original Discussion: 'The large sample size of the current study allowed us to perform several sensitivity analyses, confirming the lack of effect across the different subgroups.'
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Independent Discussion: This was a rigorously conducted, large multi-centre pragmatic trial. The protocol for the study was thorough and comprehensible. The study was pre-registered, and the protocol was published ahead of time. Overall there were few deviations from the protocol and outcomes were unchanged with per-protocol analysis. The adaptive design allowed for a more efficient study. All these factors increase confidence in relation to the robustness of the findings. Commentary: The independent discussant highlighted more strengths of the study than the investigators themselves did. The lists of strengths in the two Discussions are complementary. Future Directions: Independent Discussion: It will be important to clarify the pathophysiology of delirium so that mechanistically targeted treatments can be developed and tested Conclusion: Original Discussion: 'Among critically ill adults with high-risk of delirium, the use of prophylactic haloperidol compared with placebo did not improve 28-day survival. These findings do not support the use of prophylactic haloperidol in critically ill adults.'
Independent Discussion: It is unlikely that prophylactic haloperidol for critically ill patients on intensive care units is effective for preventing either death or delirium. Commentary: The take-home message was the same. Inferential Reproducibility: Commentary: Overall, there is considerable concordance between the two Discussions, and inferential reproducibility is generally endorsed. There is some discordance regarding the extent to which the 'negative' findings are interpreted as being 'definitive', and also in relation to the biological plausibility of the hypothesis on which this study was predicated.
Ideal attributes of an independent discussant
It is important to consider what the essential attributes would be for a second discussant. Our perspective is that the chosen individual should certainly have expertise in scientific methods and interpretation, but would not necessarily need deep content (subject matter) expertise. The discussant could, for example, clarify the limitations of the P-values in a scientific manuscript, and inject a cautionary tone when interpreting results. 8, 39 Some content expertise would be useful however, because otherwise it may be difficult to contextualise the findings of a study using systematic review, as has been recommended. 40 Importantly, even without vested interests in a particular manuscript, scientists may still have a priori beliefs and could unwittingly inject their partiality in a Discussion they intended to be impartial. Therefore, thoughtful selection of the discussants would be important and peer review of the independent Discussion would also be necessary, as with any scientific writing.
Barriers to implementation
The proposal of having a second independent discussant faces important barriers, some of which should be emphasised. If the primary authors do not include weaknesses in their own Discussion, they might be reluctant to reveal them to the independent discussant. This is a problem in particular for weaknesses that require insider knowledge of the study and its implementation. Hopefully, with a move towards more transparency and pre-registration for clinical trials and other types of research and availability of full protocols and of their revisions, this will be less of an issue. The approach of adding a discussant separate from the investigative team would create additional complexity and could result in delays to publication. However, having independent second discussants for an article is not without precedent, as some journals already publish additional Discussions immediately after the one prepared by the authors or they have influential papers accompanied by editorials. Our recommendation is that an impartial second Discussion complementing the current standard could build on this practice by providing the discussant with the protocol and raw data, rather than merely the narrative of a final article that already includes a Discussion. In order to be efficient, the process would need to be conducted expeditiously and with early engagement of the second discussant, perhaps during the revision phase of the peer review process as is common with editorial writers. Much like an editorialist, an independent discussant would fulfill the requirements for authorship as stipulated by the International Committee of Medical Journal Editors, so there should be also an academic incentive for becoming a good discussant and writing balanced, carefully thought Discussions.
Finally, an open question is whether the independent discussant may be asked also to perform the systematic review that, as was noted, is indispensable for placing results in context. Such a review may take considerable time and effort, which could delay the publication of the work. In fact, we think that the primary authors would be better suited to perform this systematic review, as ideally a systematic review should be done before the study design phase. The independent discussant may then use this review and may also judge its completeness and impartiality.
Testing whether discussions are improved
Both the investigators and an independent discussant would bring strengths to their Discussion sections. The investigators would have content and context expertise, and would be familiar with the intricacies of the study. An independent second discussant would hopefully have expertise in research methodology and would regard a study through unbiased lenses. Although much of the material included in Discussions is subjective and qualitative, there are methods by which to evaluate independent Discussions compared with the current status quo in order to assess whether the proposed methods offer any tangible improvements. For example, natural language processing (NLP), a form of computational linguistics, is one strategy to measure the tone of a Discussion with relative objectivity. NLP and machine learning approaches to text analysis have been used (among numerous uses in clinical medicine and research) to identify emotional tone in dream reports, 41 evaluate psychological states, 42 classify emotional expression in suicide notes, 43 and identify positive and negative emotional polarity. 44 Qualitative analysis of text using NLP algorithms could allow comparisons of Discussions by study authors vs independent authors. Furthermore, standardised NLP programs could ultimately be used by authors, reviewers, or editors to screen for inappropriate levels of positive tone in article Discussions in the same way that investigators and journals currently screen for inappropriate levels of text reproduction (i.e. plagiarism). Furthermore, empirical studies by metaresearchers (e.g. observational assessments or even randomised trials comparing Discussion strategies) may continue to assess whether systematic reviews of the evidence are properly done and incorporated in Discussions and whether the conclusions and recommendations for practice are commensurate with the evidence.
An example of an independent discussion
In order to demonstrate how this proposal can be operationalised, we provide an example of an independent Discussion of a recent scientific manuscript, published in the journal JAMA. 45 Following an established structure for a Discussion section (Table 1) , one of the authors (M.S.A.) wrote the independent Discussion based on the Introduction, Methods, and Results sections of the manuscript, without reading the Discussion section. Another author (G.A.M.) then extracted the relevant sections from the manuscript's Discussion (Original Discussion), and assessed commonalities and differences between the separately written Discussions (Commentary). The third author (J.P.A.I.) reviewed and edited these Commentary assessments. The example of an independent Discussion with commentary is presented in Table 2 .
Conclusion
More objective, balanced Discussions are needed in research reporting. Using second independent discussants may improve the quality of research articles and contribute to the evolving culture or research reproducibility. We acknowledge that there are still important questions about the practicality of the proposed approach, and the exact mode in which it would be best implemented. The best way to resolve these questions is by piloting the concept in a number of studies and drawing some endorsement by journals, research organisations, and funding agencies. Notwithstanding the known and unknown constraints, our opinion remains that second independent and dispassionate Discussions are feasible, and would help to combat bias, misinformation, and lack of reproducibility in science. Enhancing inferential reproducibility is necessary to the appropriate determination of whether new knowledge merits advance along the translational continuum.
